J. Sistonen
发表
A. Sajantila,
E. Vuori,
I. Ojanperä,
2007,
The American journal of forensic medicine and pathology.
M. Hayden,
B. Carleton,
G. Koren,
2010,
Pharmacogenomics.
Jukka Corander,
Guido Barbujani,
Oscar Lao,
2007,
Pharmacogenetics and genomics.
Ursula Amstutz,
Johanna Sistonen,
M. Hayden,
2011,
Journal of cardiovascular pharmacology.
E. Vuori,
A. Pelander,
I. Ojanperä,
2007,
Therapeutic drug monitoring.
M. Gentile,
T. Heliö,
S. Tuupanen,
2021,
BMC Cardiovascular Disorders.
M. Irving,
J. Koskenvuo,
L. Pelttari,
2021,
Orphanet Journal of Rare Diseases.
M. Hayden,
B. Carleton,
G. Koren,
2012,
Paediatric drugs.
M. Hayden,
B. Carleton,
G. Koren,
2012,
Pediatric Drugs.
M. Hayden,
B. Carleton,
G. Koren,
2013,
Pain research & management.
M. Hayden,
B. Carleton,
G. Koren,
2011,
Therapeutic drug monitoring.
E. Vuori,
A. Pelander,
I. Ojanperä,
2003,
Journal of analytical toxicology.
A. Pelander,
I. Ojanperä,
J. Sistonen,
2001
.
A. V. van Kuilenburg,
M. Joerger,
C. Largiadèr,
2014,
Pharmacogenomics.
M. Hayden,
G. Koren,
M. Yazdanpanah,
2012,
Clinical pharmacology and therapeutics.
M. Hayden,
B. Carleton,
G. Koren,
2010,
Pediatrics.
PHARMACOGENETIC VARIATION AT CYP2D6 , CYP2C9 , AND CYP2C19 : Population Genetic and Forensic Aspects
J. Sistonen,
2008
.
A. Sajantila,
S. Fuselli,
J. Sistonen,
2005
.
T. Ojala,
M. Gentile,
S. Ahonen,
2021,
PloS one.
P. Fariselli,
A. Sajantila,
G. Bertorelle,
2010,
Pharmacogenetics and genomics.
A. Sajantila,
J. Palo,
H. Padh,
2009,
Pharmacogenetics and genomics.
J. Sistonen,
2008
.
Gideon Koren,
Johanna Sistonen,
M. Hayden,
2010,
Thyroid : official journal of the American Thyroid Association.
T. Carrel,
G. Fiedler,
C. Largiadèr,
2014,
Therapeutic drug monitoring.
K. Nikus,
M. Gentile,
S. Ahonen,
2021,
Frontiers in Genetics.
A. Sajantila,
E. Vuori,
I. Ojanperä,
2006,
Forensic science international.
Guido Barbujani,
Fulvio Cruciani,
Antti Sajantila,
2004,
European Journal of Human Genetics.
U. Christians,
Chris Nakas,
A. Leichtle,
2017,
Metabolomics.
Influence of CYP3A5 genetic variation on everolimus maintenance dosing after cardiac transplantation
G. Fiedler,
C. Largiadèr,
P. Mohacsi,
2015,
Clinical transplantation.
S. Tishkoff,
M. Hayden,
S. R. Rassekh,
2013,
The Pharmacogenomics Journal.
U. Amstutz,
S. Aebi,
M. Joerger,
2015,
Pharmacogenomics (London).
U. Amstutz,
R. Diasio,
M. Joerger,
2015,
Clinical Cancer Research.
E. Sankila,
S. Tuupanen,
S. Myllykangas,
2022,
Translational vision science & technology.
M. Irving,
J. Koskenvuo,
L. Pelttari,
2021,
Orphanet Journal of Rare Diseases.
A. Sajantila,
S. Fuselli,
J. Sistonen,
2005,
Clinical chemistry.
C. Largiadèr,
J. Sistonen,
Yu Fu,
2012,
Clinica chimica acta; international journal of clinical chemistry.
M. Joerger,
C. Largiadèr,
J. Sistonen,
2013,
Clinical chemistry and laboratory medicine.
M. Irving,
J. Koskenvuo,
T. Kangas-Kontio,
2022,
Orphanet Journal of Rare Diseases.
M. Hayden,
B. Carleton,
G. Koren,
2010,
Pediatrics.
U. Amstutz,
R. Diasio,
M. Joerger,
2015,
Clinical Cancer Research.